DKN-01 Inhibition in Advanced Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Use of Sorafenib and/or Regorafenib in Liver Cancer (Hepatocellular Carcinoma) Subsequent to Another Systemic First-line Treatment
- Status
- TERMINATED
- Phase
- N/A
Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACE
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab
- Status
- COMPLETED
- Phase
- PHASE2
TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation
- Status
- COMPLETED
- Phase
- PHASE2
Computer-assisted Tumor Ablation for Patients With Liver Cancer
- Status
- COMPLETED
- Phase
- N/A
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
The Overall Survival of Patients With Unresectable HCC in Real-life
- Status
- RECRUITING
- Phase
- N/A
Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Adagloxad Simolenin/OBI-821 in Combination With TACE Therapy in HCC Patients With GALNT14-rs9679162-non-TT Genotype
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Anesthetic Methods on Hepatic Cancer Cell Malignancy
- Status
- COMPLETED
- Phase
- NA
Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) Subjects
- Status
- TERMINATED
- Phase
- PHASE2
TACE-HAIC vs. HAIC for Potentially Resectable HCC
- Status
- UNKNOWN
- Phase
- NA
Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea
- Status
- COMPLETED
- Phase
- NA
CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE2
Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection
- Status
- COMPLETED
- Phase
- PHASE2